Difference 69656000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
U S PHYSICAL THERAPY INC /NV (USPH) reported revenue of $780.99M and net income of $39.58M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from U S PHYSICAL THERAPY INC /NV’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Health Services.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $780.99M | $671.34M | $604.80M | $553.14M | $495.02M | $422.97M | $481.97M | $453.91M | $414.05M | $356.55M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | $149.69M | $123.92M | $121.51M | $112.02M | $117.18M | $94.45M | $112.47M | $101.66M | $90.62M | $82.01M |
| Operating income | $86.68M | $62.99M | $50.51M | $56.80M | $70.65M | $52.41M | $67.42M | $60.31M | $54.73M | $49.53M |
| Net income | $39.58M | $31.42M | $28.24M | $32.16M | $40.83M | $35.19M | $40.04M | $34.87M | $22.26M | $20.55M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 15.18M | shares 15.06M | shares 14.19M | shares 12.98M | shares 12.90M | shares 12.84M | shares 12.76M | Unavailable | Unavailable | shares 12.50M |
| Pretax income | $77.81M | $60.21M | $49.38M | $55.57M | $73.20M | $65.51M | $70.91M | $60.21M | $33.76M | $38.15M |
| Income tax expense | $19.81M | $14.61M | $12.16M | $12.16M | $15.27M | $13.02M | $13.65M | $11.37M | $6.03M | $11.88M |
| Diluted EPS | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 | $2.48 | $2.45 | Unavailable | Unavailable | Unavailable |
| Selling, general & administrative | $69.26M | $58.29M | $51.95M | $46.11M | $46.53M | $42.04M | $45.05M | $41.35M | $35.89M | $32.48M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $35.57M | $41.36M | $152.82M | $31.59M | $28.57M | $32.92M | $23.55M | $23.37M | $21.93M | $20.05M |
| Total assets | $1.20B | $1.17B | $997.24M | $858.15M | $749.43M | $594.36M | $630.50M | $443.17M | $418.98M | $351.23M |
| Current assets | $139.99M | $137.58M | $233.38M | $111.27M | $95.17M | $87.64M | $85.39M | $79.21M | $77.08M | $65.96M |
| Total liabilities | $433.81M | $408.42M | $345.00M | $373.59M | $296.98M | $184.39M | $181.39M | $92.35M | $110.34M | $162.54M |
| Current liabilities | $139.04M | $116.28M | $102.18M | $85.49M | $83.48M | $93.49M | $60.56M | $41.95M | $39.55M | $24.62M |
| Total equity incl. NCI | $476.89M | $490.02M | $477.41M | $317.05M | $297.18M | $277.63M | $241.70M | $216.88M | $206.07M | $188.69M |
| Temporary (mezzanine) equity | $293.31M | $269.02M | $174.83M | $167.52M | $155.26M | $132.34M | $137.75M | $133.94M | $102.57M | $0 |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $64.25M | $59.04M | $51.80M | $51.90M | $46.27M | $41.91M | $46.23M | $44.75M | $44.71M | $38.84M |
| Goodwill | $692.39M | $667.15M | $509.57M | $494.10M | $434.68M | $345.65M | $317.68M | $293.52M | $271.34M | $226.81M |
| Long-term debt | $152.59M | $142.53M | $138.99M | $175.83M | $117.59M | $16.60M | $50.36M | $38.40M | $56.73M | $50.60M |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $75.06M | $74.94M | $81.98M | $58.54M | $76.41M | $100.00M | $62.45M | $73.00M | $56.53M | $51.05M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$36.71M | -$149.45M | -$45.02M | -$81.27M | -$124.14M | -$51.20M | -$37.99M | -$23.91M | -$43.58M | -$32.49M |
| Financing cash flow | -$44.14M | -$36.95M | $84.27M | $25.76M | $43.38M | -$39.42M | -$24.28M | -$47.66M | -$11.06M | -$14.29M |
| Net change in cash | -$5.79M | -$111.46M | $121.23M | $3.03M | -$4.35M | $9.37M | $180.00K | $1.44M | $1.89M | $4.27M |
| Stock-based compensation | $8.27M | $7.82M | $7.24M | $7.26M | $7.87M | $7.92M | $6.98M | $5.94M | $5.03M | $4.96M |
| Common dividends paid | $27.36M | $26.54M | $24.13M | $21.32M | $18.76M | $4.11M | $14.56M | $11.66M | $10.07M | $8.51M |
| Common share repurchases | $5.57M | $0 | $0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $22.39M | $18.68M | $15.70M | $14.74M | $11.59M | $10.53M | $10.10M | $9.76M | $9.71M | $8.78M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 19.2% | 18.5% | 20.1% | 20.3% | 23.7% | 22.3% | 23.3% | 22.4% | 21.9% | 23.0% |
| Operating margin | 11.1% | 9.4% | 8.4% | 10.3% | 14.3% | 12.4% | 14.0% | 13.3% | 13.2% | 13.9% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 1.1% | 1.2% | 1.2% | 1.3% | 1.6% | 1.9% | 1.4% | 1.3% | 1.2% | 1.4% |
| Current ratio | 1.01x | 1.18x | 2.28x | 1.30x | 1.14x | 0.94x | 1.41x | 1.89x | 1.95x | 2.68x |
| Revenue YoY growth | 16.3% | 11.0% | 9.3% | 11.7% | 17.0% | -12.2% | 6.2% | 9.6% | 16.1% | Unavailable |
| Net margin | 5.1% | 4.7% | 4.7% | 5.8% | 8.2% | 8.3% | 8.3% | 7.7% | 5.4% | 5.8% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.32x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 25.5% | 24.3% | 24.6% | 21.9% | 20.9% | 19.9% | 19.2% | 18.9% | 17.9% | 31.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open USPH in the interactive workspace to inspect any figure back to its filing.
Source filings
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.